Delineation of upstream signaling events in the salmonella pathogenicity island 2 transcriptional activation pathway

Journal of Bacteriology
Charles C Kim, S Falkow

Abstract

Survival and replication in the intracellular environment are critical components of the ability of Salmonella enterica serovar Typhimurium to establish systemic infection in the murine host. Intracellular survival is mediated by a number of genetic loci, including Salmonella pathogenicity island 2 (SPI2). SPI2 is a 40-kb locus encoding a type III secretion system that secretes effector molecules, which permits bacterial survival and replication in the intracellular environment of host cells. A two-component regulatory system, ssrAB, is also encoded in SPI2 and controls expression of the secretion system and effectors. While the environmental signals to which SPI2 responds in vivo are not known, activation of expression is dependent on OmpR and can be stimulated in vitro by chelation of cations or by a shift from rich to acidic minimal medium. In this work, we demonstrated that SPI2 activation is associated with OmpR in the phosphorylated form (OmpR-P). Mutations in envZ and ackA-pta, which disrupted two distinct sources of OmpR phosphorylation, indicated that SPI2 activation by chelators or a shift from rich to acidic minimal medium is largely dependent on functional EnvZ. In contrast, the PhoPQ pathway is not required for SPI...Continue Reading

Associated Datasets

Dec 14, 2005·Charlie Kim, Stanford Microarray Database

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K Y Leung, B B Finlay
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S ForstM Inouye
Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P I FieldsF Heffron
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·L J KenneyT J Silhavy
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·K V PrasadC E Rudd
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·J E SheaD W Holden
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·H OchmanE A Groisman
Apr 21, 1999·Molecular Microbiology·J DeiwickM Hensel
Aug 24, 1999·Infection and Immunity·R M TsolisA J Bäumler
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Jun 9, 2000·Molecular Microbiology·M J WorleyF Heffron
Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y ZhuM Inouye
Jan 11, 2000·Nucleic Acids Research·G SherlockJ M Cherry
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·V G TusherG Chu
Nov 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michelle L ZaharikB Brett Finlay
Nov 28, 2002·Molecular Microbiology·Takeshi YoshidaMasayori Inouye
Jan 10, 2003·Nucleic Acids Research·Jeremy GollubGavin Sherlock
Apr 17, 2003·BMC Bioinformatics·Charles C Kim, Stanley Falkow
May 20, 2003·Molecular Microbiology·Xiuhong FengLinda J Kenney
Jul 17, 2003·Cellular Microbiology·Scott R Waterman, David W Holden

❮ Previous
Next ❯

Citations

Apr 17, 2010·Molecules and Cells·Sangyong LimSangryeol Ryu
Aug 18, 2009·Applied and Environmental Microbiology·Silvia VilchesSusana Merino
Jan 15, 2013·Applied and Environmental Microbiology·Seema DasPrasad Gyaneshwar
Jan 24, 2006·Infection and Immunity·Sofia Eriksson YgbergMikael Rhen
Jan 24, 2006·Infection and Immunity·Olivia Rodríguez-MoralesEdmundo Calva
Mar 10, 2005·Microbiology and Molecular Biology Reviews : MMBR·Alan J Wolfe
Dec 1, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Er-Yuan ChuangHsing-Wen Sung
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jeongjoon Choi, Eduardo A Groisman
Mar 7, 2009·Current Opinion in Microbiology·Ephraim Fass, Eduardo A Groisman
Jun 14, 2005·Molecular Microbiology·Jetta J E Bijlsma, Eduardo A Groisman
Jan 20, 2011·Biotechnology and Bioengineering·Elizabeth J Clarke, Christopher A Voigt
Oct 22, 2011·Microbiology·Avelino Álvarez-OrdóñezColin Hill
Mar 8, 2011·Cell·Nicholas ArpaiaGregory M Barton
Aug 15, 2006·International Journal of Medical Microbiology : IJMM·Stefanie LöberMichael Hensel
Oct 28, 2017·Frontiers in Microbiology·Christopher J Anderson, Melissa M Kendall
Nov 10, 2017·Scientific Reports·Travis J BourretAndrés Vázquez-Torres

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.